English
简体中文
Total: £ 56.28
2026-03-24 | Pages: 115 | Tables: 115
The global mRNA Drug market was valued at US$ 448 million in 2025 and is anticipated to reach US$ 627 million by 2032, at a CAGR of 5.0% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape...
2026-03-24 | Pages: 154 | Tables: 153
The global Triptans market was valued at US$ 1256 million in 2025 and is anticipated to reach US$ 1625 million by 2032, at a CAGR of 3.9% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscap...
2026-03-24 | Pages: 118 | Tables: 125
The global Meropenem Powder market was valued at US$ 183 million in 2025 and is anticipated to reach US$ 230 million by 2032, at a CAGR of 3.2% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-03-24 | Pages: 114 | Tables: 119
The global Inflammatory Bowel Disease Drugs market was valued at US$ 22670 million in 2025 and is anticipated to reach US$ 31230 million by 2032, at a CAGR of 4.8% from 2026 to 2032.Inflammatory Bowel Disease Drugs refer to pharmaceutical therapies u...
2026-03-23 | Pages: 135 | Tables: 129
The global Liver Supplements for Dogs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-23 | Pages: 142 | Tables: 139
The global HPMC Plant Hollow Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-23 | Pages: 109 | Tables: 115
The global Protein-Losing Enteropathy Medication market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-03-23 | Pages: 131 | Tables: 128
The global Hydroquinone Creams market was valued at US$ 1280 million in 2025 and is anticipated to reach US$ 1765 million by 2032, at a CAGR of 4.7% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econom...
2026-03-20 | Pages: 104 | Tables: 90
The global 14C-Urea Helicobacter Pylori Test Kit market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-03-20 | Pages: 113 | Tables: 110
The global Methyl Salicylate API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape...
2026-03-20 | Pages: 122 | Tables: 126
The global Portable Bottled Medicated Oil market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic ...
2026-03-20 | Pages: 122 | Tables: 125
The global Herbal Rolling Ball Type Medicated Oil market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-03-20 | Pages: 122 | Tables: 125
The global Rolling Ball Type Medicated Oil market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic...
2026-03-20 | Pages: 105 | Tables: 107
The global HIV Prevention Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-20 | Pages: 116 | Tables: 112
The global Biologics for Severe Asthma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
